Fingerprint
Dive into the research topics of 'Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Joleen Hubbard, Charles Erlichman, David O. Toft, Rui Qin, Bridget A. Stensgard, Sara Felten, Cynthia Ten Eyck, Gretchen Batzel, S. Percy Ivy, Paul Haluska
Research output: Contribution to journal › Article › peer-review